Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of TML-023 ointment for proliferative superficial infantile hemangioma
CTR20251681Phase 3Completed
- Sponsor
- Wuhan Kefu New Drug
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol in Capillary Haemangioma, sponsored by Wuhan Kefu New Drug. Started Jun 2025; status: completed.
02
Drugs
timolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on CTR20251681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251681.